Featured Research

from universities, journals, and other organizations

Allergy tablet approval warrants caution for some

Date:
April 2, 2014
Source:
American College of Allergy, Asthma and Immunology (ACAAI)
Summary:
A pill a day keeps spring allergies away. In a perfect world, it would be that easy. And for those suffering from an allergy to some grasses, the Food and Drug Administration‘s (FDA) approval of the oral dissolvable tablets designed to help treat symptoms may be beneficial. But for the majority of seasonal sufferers allergic to pollens from the more than 30 other pollinating species, relief isn’t that easy.

A pill a day keeps spring allergies away. In a perfect world, it would be that easy. And for those suffering from an allergy to some grasses, the Food and Drug Administration's (FDA) approval of the oral dissolvable tablets designed to help treat symptoms may be beneficial. But for the majority of seasonal sufferers allergic to pollens from the more than 30 other pollinating species, relief isn't that easy.

"The approval of oral immunotherapy tablets is advancement in the right direction," said allergist Michael Foggs, MD, president of the American College of Allergy, Asthma and Immunology (ACAAI). "It's an additional treatment option for those who are allergic to some types of grasses, but not those allergic to other varieties of grass, trees and weeds."

According to ACAAI, those with seasonal allergies can be affected by the pollen of 11 different types of weeds and trees, and eight varieties of grass. Mold is also problematic in the spring, summer and fall months.

Fortunately, there is a long-standing solution for those suffering from multiple allergies. Immunotherapy, also known as allergy shots, has been used for 100 years and is a natural treatment. Each injection can be customized to an individual's allergic needs. Allergy shots can modify and prevent allergy progression while also relieving symptoms. They are also fast acting and cost-efficient.

"It would be ideal if tablets could be customized like allergy shots, but that's not on the horizon yet," said Dr. Foggs. "Since allergy treatment is not a one-size-fits-all approach, treatment needs to be tailored to an individual's needs."

Although the approved tablets are beneficial only for those suffering from some forms of grass allergy, the FDA's approval will help open the door for others getting approved, such as tablets for ragweed and dust mite allergy.

The best way to conquer allergy symptoms is to avoid allergens, according to the ACAAI. During the spring sneezing season, sufferers should: • Limit time outdoors when pollen counts are highest (midday and afternoon hours) • Keep windows in the car and home closed • Wash hair after working or exercising outdoors

Allergy sufferers should talk with their board-certified allergist to learn which treatment is best suited for their needs.


Story Source:

The above story is based on materials provided by American College of Allergy, Asthma and Immunology (ACAAI). Note: Materials may be edited for content and length.


Cite This Page:

American College of Allergy, Asthma and Immunology (ACAAI). "Allergy tablet approval warrants caution for some." ScienceDaily. ScienceDaily, 2 April 2014. <www.sciencedaily.com/releases/2014/04/140402105559.htm>.
American College of Allergy, Asthma and Immunology (ACAAI). (2014, April 2). Allergy tablet approval warrants caution for some. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/04/140402105559.htm
American College of Allergy, Asthma and Immunology (ACAAI). "Allergy tablet approval warrants caution for some." ScienceDaily. www.sciencedaily.com/releases/2014/04/140402105559.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins